We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Oncothyreon to Receive Payment From Merck KGaA on Stimuvax Development
Oncothyreon to Receive Payment From Merck KGaA on Stimuvax Development
December 17, 2007
Oncothyreon Inc. on Monday announced the completion of the transfer of certain assays and methodology related to Stimuvax to Merck KGaA of Darmstadt, Germany. RTTNews
